Named on one round in the feed.
Since 2026-04-19
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Pulnovo Medical Pulnovomed develops and conducts clinical trials for innovative treatments in pulmonary hypertension and heart failure, specifically focusing on pulmonary artery denervation technology. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-04-19 | [ LEAD ] |
No one else named on these rounds.